Clinical Trial Update: An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)

View source ↗

Summary

An observational study validating the DermCLCI-p instrument for cumulative life course impairment in adults with moderate to severe chronic plaque psoriasis has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Snippet

Sponsor: AbbVie | Conditions: Psoriasis | Status: COMPLETED